arrow
A

Ana Maia

the netherlands cancer institute
H指数:15
被引数:1,862

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EO2401 PEPTIDE IMMUNOTHERAPY plus NIVOLUMAB plus /- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: TREATMENT STRATEGY OPTIMIZATION IN THE PHASE 1/2 STUDY EOGBM1-18 / ROSALIE (NCT04116658)

EO2401多肽免疫疗法联合纳武利尤单抗及/或贝伐珠单抗治疗首次复发的胶质母细胞瘤:EOGBM1-18 / ROSALIE(NCT04116658)研究中的治疗策略优化(I/II期研究)

2025-11-010
OAAI
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer

基于人类与共生抗原之间模拟的策略,用于开发癌症的新一代免疫疗法家族

2025-02-200
OA
Staining of activated β??????????????2-integrins in combination with CD137 and CD154 for sensitive identification of functional antigen-specific CD4+ and CD8+ T cells

活化的 β 染色 ?????????????????? 2整合素与CD137和CD154结合用于功能性抗原特异性CD4和CD8 T细胞的敏感鉴定

2023-01-192
OAAI
Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA

p53-regulated增强子rna的全基因组谱分析揭示了由lncRNA控制的增强子子集

2015-03-27162
OAAI